Treatment of Pancreas Cancer with the CyberKnife® System

March 11, 2020

After graduating from Madras Medical College in India, Dr. Anand Mahadevan completed his surgical and oncology training in the UK. After a 2-year fellowship in the Harvard Radiation Oncology program, he went on to become a staff radiation oncologist at the Beth Israel Deaconess Medical Center, Harvard Medical School faculty and Assistant Program director of the Harvard Radiation Oncology Program. He is currently the Professor and Chairman of Radiation Oncology at the Geisinger Health System. His clinical interests and contributions are primarily in Stereotactic radiation to Liver and Pancreatic tumors, Oligometastasis and NeuroOncology.

Moderated by: Joost Nuyttens, M.D. – Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Dr. Nuyttens is an assistant professor in radiation oncology. He is working since 2001 in the Department of Radiation Oncology at Erasmus MC Cancer Institute, Rotterdam in the Netherlands with a special focus on thoracic, and digestive cancer. He has published more than 100 publications in international journals, 5 book chapters on stereotactic radiotherapy for lung tumors and 1 on intra-operative brachytherapy. In the last 15 years, Dr. Nuyttens has been using the CyberKnife® system  to treat early stage NSCLC, oligometastasis, and pancreatic cancer. He is also a project member of the Holland Proton Therapy Center in Delft.

In 1996, Dr Nuyttens graduated from the Medical School at Ghent University in Belgium where he also did his post-graduate medical specialty training in radiotherapy. He then completed his education with advanced Radiation Oncology training at the Medical University of South Carolina (USA) and was a research fellow at the William Beaumont Hospital in Detroit (USA).